PKPissared Khuituan

Pissared Khuituan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pissared Khuituan has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The chalcone derivative DN-053 attenuates renal fibrosis and inhibits p38 MAPK and STAT3 signaling in renal fibroblasts

    by Sudaphon Srichan, Pissared Khuituan, Krittee Dejyong, Natapol Duangtum, Julaluk Jiangsakul, Chayada Yoksiri, Nattanun Hautavanija, Sukrit Sangjun, Fittree Hayeeawaema, Warinthorn Chavasiri, et al.

  • Lacticaseibacillus rhamnosus SD11 improves gastrointestinal functions in multiple low doses of streptozotocin-induced type 1 diabetic mice

    by Jongdee Nopparat, Fittree Hayeeawaema, Saranya Peerakietkhajorn, Chittipong Tipbunjong, Nawiya Huipao, Rawee Teanpaisan, Pissared Khuituan


  • Open Access

    Antispasmodic and Anti-inflammatory Effects of Kratom Leaf Extract on Acetic Acid-induced Ulcerative Colitis in Mice

    by Sakda Pradab, Chutha Takahashi Yupanqui, Chittipong Tipbunjong, Fittree Hayeeawaema, Narumon Sengnon, Juraithip Wungsintaweekul, Pissared Khuituan

    Background/Aim: Ulcerative colitis (UC) is colonic inflammation associated with increased production of pro-inflammatory cytokines, oxidative stress, and disturbances of immune responses. Mitragynine is the most abundant active alkaloid in Mitragyna speciosa (kratom) and may have anti-inflammatory, antioxidant, and antispasmodic properties. In this study, we investigated the palliative effects of mitragynine in kratom leaf extract on the symptoms of UC. Materials and Methods: Mice were divided into six groups (n=9): control; colitis; colitis plus syrup with kratom extract containing 5, 10, or 20 mg/kg mitragynine; and a positive control group treated with 4 mg/kg loperamide. The treatments were orally administered for 5 days after colitis was induced by transrectal administration of 5% acetic acid. Results: The results showed that syrup with 10 and 20 mg/kg mitragynine significantly alleviated colonic tissue damage caused by acetic acid-induced colitis. Furthermore, the disease activity index, colonic weight, colonic lesions, and levels of malondialdehyde and inflammatory cytokines (tumor necrosis factor-α and interleukin-1β) decreased in these groups in comparison with the colitis-only group. With regard to antispasmodic activity, kratom extract significantly increased colonic smooth muscle relaxation by acting on μ-opioid receptor signaling and inhibited induced muscular contraction in mice with colitis. Moreover, kratom extract attenuated nitric oxide levels and enhanced the phagocytic activity of mouse peritoneal macrophages. Conclusion: Kratom leaf extract, which contains mitragynine, alleviated acetic acid-induced colitis in mice by modulating immune responses and by its anti-inflammatory, antioxidative, and antispasmodic effects. Therefore, kratom leaves may be an effective therapeutic candidate for subsequent development as a multitarget drug for UC.


  • Open Access

    Kratom syrup reduces colitis severity and enhances intestinal barrier integrity in acetic acid-induced colitis mice

    by Narumon Sengnon, Juraithip Wungsintaweekul, Nattha Kaewnopparat, Dujhathai Anekchai, Siprapha Naknoi, Nawiya Huipao, Sakda Pradab, Chittipong Tipbunjong, Pissared Khuituan


  • Open Access

    Live and heat-killed Leuconostoc mesenteroides counteract the gastrointestinal dysfunction in chronic kidney disease mice through intestinal environment modulation

    by Fittree Hayeeawaema, Natthawan Sermwittayawong, Chittipong Tipbunjong, Nawiya Huipao, Paradorn Muangnil, Pissared Khuituan

    Probiotics are well-known therapeutic agents for managing constipation and have been used to improve chronic kidney disease (CKD) progression. However, heat-killed probiotics on CKD remain inadequately explored. This study aimed to evaluate the probiotic potential of lactic acid bacteria derived from natural sources and to investigate the effects of both live and heat-killed Leuconostoc mesenteroides (Ln.m) on renal and gastrointestinal functions in CKD mice. Ln.m was selected from acid and bile salt intolerance tests, non-hemolytic activity, and antibiotic sensitivity. CKD mice demonstrated significantly elevated blood urea nitrogen (BUN) and creatinine levels compared to control mice (p < 0.001 and p < 0.01). Treatment with live and heat-killed Ln.m significantly reduced BUN and creatinine levels in CKD mice (p < 0.01 and p < 0.05). Additionally, kidney damage observed in CKD mice compared to control mice, including glomerular necrosis, tubular dilatation, inflammation, and fibrosis, was significantly alleviated following live and heat-killed Ln.m treatments. CKD-induced gastrointestinal dysfunction was characterized by an imbalance in Firmicutes/Bacteroidota populations, increased colonic uremic toxin (p < 0.01), reduced fecal short-chain fatty acids (SCFAs) (p < 0.05), and constipation. Treatment with live and heat-killed Ln.m restored gut microbiota, decreased uremic toxin (p < 0.001), increased SCFAs (p < 0.05), and alleviated constipation. In summary, both live and heat-killed Ln.m effectively alleviated gastrointestinal dysfunction and renal damage in CKD mice, primarily through modulation of the intestinal environment. These findings highlight the therapeutic potential of live and heat-killed Ln.m as the gastrointestinal dysfunction treatment in CKD.


  • Open Access

    Toxicological evaluation of Sargassum plagiophyllum extract in male mice

    by Chittipong Tipbunjong, Rattanaporn Sengkhim, Sitthiwach Thantongsakul, Saranya Peerakietkhajorn, Jaruwan Mayakun, Nawiya Huipao, Pissared Khuituan

    Purpose: To provide valid scientific evidence for the safety of Sargassum plagiophyllum extract in an animal model. Methods: Sargassum plagiophyllum extract (SPE) was obtained via water extraction using an autoclave at 121°C for 20 min. The SPE was administered to 4 groups of adult male mice via gavage once a day for 21 days. The treatment groups received different doses of SPE, i.e., 100, 500, 1000, and 2000 mg/kg. Control mice were given distilled water. Body weight, and feed and water intakes were recorded. The toxicity of SPE was assessed by determining blood, biochemical, and histopathological indices. Results: Intake of SPE for 21 days did not produce any impact on body mass, feed intake and water intake, even at 2000 mg/kg. Hematological parameters were also unaffected. Biochemical analysis of blood/serum revealed normal levels of blood urea nitrogen (BUN), creatinine, alanine transaminase (ALT), aspartate transaminase (AST), and alkaline phosphatase (ALP) in all treatment groups, when compared to control group. Moreover, histopathological studies confirmed healthy conditions of the liver, kidney, colon, and other organs in all treatment groups. Conclusion: These results from a mouse model provide basic scientific evidence of the safety of consuming Sargassum plagiophyllum extract, even at high doses thus expanding its potential use as a medication for improving health.


  • Open Access

    A novel model of adenine-induced chronic kidney disease-associated gastrointestinal dysfunction in mice: The gut-kidney axis

    by Fittree Hayeeawaema, Paradorn Muangnil, Julaluk Jiangsakul, Chittipong Tipbunjong, Nawiya Huipao, Pissared Khuituan


  • Open Access

    Sargassum plagiophyllum Extract Enhances Colonic Functions and Modulates Gut Microbiota in Constipated Mice

    by Pissared Khuituan, Nawiya Huipao, Nilobon Jeanmard, Sitthiwach Thantongsakul, Warittha Promjun, Suwarat Chuthong, Chittipong Tipbunjong, Saranya Peerakietkhajorn

    Constipation is a symptom that is widely found in the world’s population. Various dietary supplementations are used to relieve and prevent constipation. Seaweed is widely used for its health benefits. In this study, we aimed to investigate the effects of Sargassum plagiophyllum extract (SPE) on functions of the gastrointestinal tract and gut microbiota. The results show that SPE pretreatment increased the frequency of gut contraction, leading to reduce gut transit time. SPE pretreatment also significantly increased the secretion of Cl− and reduced Na+ absorption, increasing fecal water content in constipated mice (p < 0.05). In addition, the Bifidobacteria population in cecal contents was significantly higher in constipated mice pretreated with 500 mg/kg SPE for 14 days than in untreated constipated mice (p < 0.05). Our findings suggest that SPE can prevent constipation in loperamide-induced mice. This study may be useful for the development of human food supplements from S. plagiophyllum, which prevent constipation.


  • Open Access

    Fluoxetine Affects Intestinal Motility via 5-HT3 and Muscarinic Receptors in ex vivo Mouse Model

    by Pissared Khuituan, Chotika Nhaemchei, Sakda Pradab, Sakena K-Da, Nipaporn Konthapakdee

  • Open Access

    Effects of Sargassum plagiophyllum extract pretreatment on tissue histology of constipated mice

    by Rattanaporn Sengkhim, Saranya Peerakietkhajorn, Nilobon Jeanmard, Supattra Pongparadon, Pissared Khuituan, Thanvarin Thitiphatphuvanon, Piyaporn Surinlert, Chittipong Tipbunjong

    Purpose: To evaluate the toxicity of the dried seaweed, Sargassum plagiophyllum, extract (SPE) pretreatment in constipated mice.Methods: The dried seaweed powder was mixed with distilled water and extracted by autoclave at 121°C. Antioxidant activity of the extract was determined by 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay. Human normal colon cells were pretreated with SPE at 0 - 100 μg/mL for 24 h before challenging them with 100 μM hydrogen peroxide (H2O2). Intracellular reactive oxygen species (ROS) were quantified using 2',7'- dichlorodihydrofluorescein diacetate (H2DCFDA). Male ICR mice were pretreated for 14 consecutive days with SPE at 100, 500 and 1,000 mg/kg or lactulose at 500 mg/kg. Body weight and food intake were recorded daily. Constipation was induced with loperamide on days 12, 13 and 14 and fecal pellets evacuated over a 4-hr period. The ileum, liver, kidney, and spleen were collected for histopathological examination.Results: The IC50 for the radical scavenging capacity of SPE was 343.90 ± 4.21 μg/mL compared to 14.14 ± 0.71 μg/mL for ascorbic acid. Pretreatment with SPE was significantly reduced ROS production in human normal colon cells. Oral administration of all doses of SPE and lactulose for 14 consecutive days had no effect on food intake or body weight when compared to the normal control group. Defecation was significantly more frequent in mice pretreated with SPE at 100 mg/kg than in the constipation control group. Histopathological examination of the ileum, liver, kidney and spleen of pretreated constipated mice revealed no toxic effect from either SPE or lactulose. On the other hand, the loss of mucus-producing cells in the ileum of constipated mice was significantly lower in mice pretreated with SPE.Conclusions: These findings support the safety of SPE supplementation and may broaden itsapplication in clinical fields as an alternative drug or supplement for constipation management.